生物标志物的风险
Biomarker Jeopardy.
作者信息
Kurtin Sandra E, Henglefelt Alyssa, Mistry Haleigh
机构信息
The University of Arizona Cancer Center, Phoenix, Arizona.
HonorHealth - Virginia G. Piper Cancer Care Network, Scottsdale, Arizona.
出版信息
J Adv Pract Oncol. 2022 Apr;13(3):292-297. doi: 10.6004/jadpro.2022.13.3.22. Epub 2022 May 23.
In the popular Biomarker Jeopardy session, Sandra E. Kurtin, PhD, ANP-C, AOCN®, Alyssa Henglefelt, PharmD, BCOP, and Haleigh Mistry, MS, PA-C, paired biomarkers with tumor types for which their expression is most commonly used to determine targeted therapy, identified key assays used to measure common biomarkers, and discussed guidelines for biomarker testing.
在广受欢迎的“生物标志物问答”环节中，医学博士、高级护理实践师、美国肿瘤护理认证协会会员（AOCN®）桑德拉·E·库尔廷、药学博士、肿瘤化疗执业药师（BCOP）艾丽莎·亨格尔费尔特以及医师助理（PA-C）、理学硕士海莉·米斯特里，将生物标志物与最常用于确定靶向治疗的肿瘤类型进行了配对，确定了用于测量常见生物标志物的关键检测方法，并讨论了生物标志物检测的指南。
Zotero 插件